Premium
Ocuphire Pharma Inc (OCUP)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol ... Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.17 | 1.17 | 1.17 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.17 | 1.17 | 1.17 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.17 | 1.17 | 1.17 | 0 | 0 | CS |
| 26 | -0.1 | -7.87401574803 | 1.27 | 1.49 | 1.0715 | 29383 | 1.28180507 | CS |
| 52 | -1.26 | -51.8518518519 | 2.43 | 2.5002 | 1.0715 | 108268 | 1.70671258 | CS |
| 156 | -2.22 | -65.4867256637 | 3.39 | 6.6 | 1.0715 | 171305 | 3.12251277 | CS |
| 260 | -4.76 | -80.2698145025 | 5.93 | 13.812 | 1.0715 | 360169 | 4.2489437 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
